This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006;7(2):126-7.

doi: 10.1080/15622970600685424.

Addressing the limitations of the CATIE study

Siegfried Kasper, Dietmar Winkler

PMID: 16684687
DOI: 10.1080/15622970600685424

Comment

Addressing the limitations of the CATIE study

Siegfried Kasper et al. World J Biol Psychiatry. 2006.

. 2006;7(2):126-7.

doi: 10.1080/15622970600685424.

Authors

Siegfried Kasper, Dietmar Winkler

PMID: 16684687
DOI: 10.1080/15622970600685424

No abstract available

PubMed Disclaimer

Comment on

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Lieberman JA, et al. N Engl J Med. 2005 Sep 22;353(12):1209-23. doi: 10.1056/NEJMoa051688. Epub 2005 Sep 19. N Engl J Med. 2005. PMID: 16172203 Clinical Trial.

Similar articles

The CATIE study and its implications for antipsychotic drug use.
Janicak PG. Janicak PG. Essent Psychopharmacol. 2006;7(1):53-63. Essent Psychopharmacol. 2006. PMID: 16989293 No abstract available.
Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study.
Möller HJ. Möller HJ. Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):371-2. doi: 10.1007/s00406-005-0634-2. Eur Arch Psychiatry Clin Neurosci. 2005. PMID: 16382376 No abstract available.
Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs.
Angst J, Bech P, Bobon D, Engel R, Hippius H, Janzen GJ, Lecrubier Y, Lingjaerde O, Möller HJ, Montgomery S, et al. Angst J, et al. Pharmacopsychiatry. 1991 Sep;24(5):149-52. doi: 10.1055/s-2007-1014459. Pharmacopsychiatry. 1991. PMID: 1685571 Review. No abstract available.
[Clinical evaluation of cyamemazine].
Nurowska K. Nurowska K. Psychiatr Pol. 1983 Sep-Dec;17(5-6):389-95. Psychiatr Pol. 1983. PMID: 6142492 Clinical Trial. Polish. No abstract available.
[Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
van Berkel M, Bogers JP, Bouvy PF. van Berkel M, et al. Tijdschr Psychiatr. 2007;49(1):37-41. Tijdschr Psychiatr. 2007. PMID: 17225204 Review. Dutch.

See all similar articles

Cited by

EPA guidance on improving the image of psychiatry.
Möller-Leimkühler AM, Möller HJ, Maier W, Gaebel W, Falkai P. Möller-Leimkühler AM, et al. Eur Arch Psychiatry Clin Neurosci. 2016 Mar;266(2):139-54. doi: 10.1007/s00406-016-0678-5. Epub 2016 Feb 13. Eur Arch Psychiatry Clin Neurosci. 2016. PMID: 26874959
Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges.
Salem H, Nagpal C, Pigott T, Teixeira AL. Salem H, et al. Curr Neuropharmacol. 2017;15(5):789-798. doi: 10.2174/1570159X14666161208153644. Curr Neuropharmacol. 2017. PMID: 27928948 Free PMC article. Review.
Effectiveness studies: advantages and disadvantages.
Möller HJ. Möller HJ. Dialogues Clin Neurosci. 2011;13(2):199-207. doi: 10.31887/DCNS.2011.13.2/hmoeller. Dialogues Clin Neurosci. 2011. PMID: 21842617 Free PMC article. Review.
Does olanzapine warrant clinical pharmacokinetic monitoring in schizophrenia?
Schwenger E, Dumontet J, Ensom MH. Schwenger E, et al. Clin Pharmacokinet. 2011 Jul;50(7):415-28. doi: 10.2165/11587240-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21651311 Review.
Five-year trend of antipsychotic prescription practices in a district Hospital in Ghana: A retrospective study.
Daliri DB, Afaya A, Laari TT, Fredrick A, Ankamah AG, Annan S, Abagye N. Daliri DB, et al. Neuropsychopharmacol Rep. 2023 Sep;43(3):434-439. doi: 10.1002/npr2.12372. Epub 2023 Aug 13. Neuropsychopharmacol Rep. 2023. PMID: 37574802 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information